Oxidative stress and heart disease: Cardiac dysfunction, nutrition, and gene therapy

Current Hypertension Reports

Volumn 5, Issue 3, 2003, Pages 215-220

  Cantor, Elliott J F ^b   Mancini, Enrico V ^b   Seth, Rishi ^b   Yao, Xing Hai ^b   Netticadan, Thomas ^a  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOVIRUS VECTOR; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CALCIUM CHANNEL L TYPE; CALCIUM ION; COMPLEMENTARY DNA; COPPER ZINC SUPEROXIDE DISMUTASE; DOUBLE STRANDED DNA; PLACEBO; POLYPHENOL DERIVATIVE; PROANTHOCYANIDIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; RETROVIRUS VECTOR; SUPEROXIDE DISMUTASE; THIOCTIC ACID; VITAMIN D;

ADENO ASSOCIATED VIRUS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CALCIUM TRANSPORT; CLINICAL TRIAL; GENE THERAPY; GRAPE JUICE; HEART DISEASE; HEART INFARCTION PREVENTION; HEART PROTECTION; HUMAN; LIPID PEROXIDATION; NONHUMAN; NUTRITIONAL HEALTH; OXIDATIVE STRESS; PATHOGENESIS; RED WINE; REVIEW; SCAVENGING SYSTEM; SODIUM CALCIUM EXCHANGE; VIRAL GENE DELIVERY SYSTEM; VITAMIN SUPPLEMENTATION; ADENOVIRUS; ANIMAL; GENE VECTOR; GENETICS; METABOLISM; PHYSIOLOGY; RETROVIRUS; WINE;

ADENOVIRIDAE; ANIMALS; GENE THERAPY; GENETIC VECTORS; HEART DISEASES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RETROVIRIDAE; WINE;

EID: 0141464922     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-003-0023-z     Document Type: Review

References (48)

1. Lang D: Cardiac hypertrophy and oxidative stress: a leap of faith or stark reality? Heart 2002, 87:316-317.
2. Dhalla NS, Temsah RM, Netticadan T: Role of oxidative stress in cardiovascular disease. J Hypertens 2000, 18:655-673.
3. Searles CD: The nitric oxide pathway and oxidative stress in heart failure. Congest Heart Fail 2002, 8:142-147.
4. Blokhina O, Virolainen E, Fagerstedt KV: Antioxidants, oxidative damaged and oxygen deprivation stress: a review. Ann Bot (Lond) 2002, 91:179-194.
5. Choudhary G, Dudley S: Heart failure, oxidative stress, and ion channel modulation. Congest Heart Fail 2002, 8:148-155.
6. Guzik TJ, West NEJ, Pillai R, et al.: Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels. Hypertension 2002, 39:1088-1094.
7. Hingtgen SD, Davisson RL: Gene therapeutic approaches to oxidative stress-induced cardiac disease: principles, progress, and prospects. Antioxid Redox Signal 2001, 3:433-49.
8. Lefer DJ, Granger, DN: Oxidative stress and cardiac disease. Am J Med 200, 109:315-323.
9. Engelhardt JF: Redox-mediated gene therapies for environmental injury: approaches and concepts. Antioxid Redox Signal 1999, 1:5-27.
10. Chen Z, Siu B, Ho YS, et al.: Overexpression of Mn-SOD protects against myocardial ischemai/reperfusion injury in transgenic mice. J Mol Cell Cardiol 1998, 30:2281-2289.
11. Yang L, Quan S, Abraham NG: Retrovirus-mediated HO gene transfer into endothelial cells protects against oxidant-induced injury. Am J Physiol 1999, 277:L127-L133.
12. Melo LG, Agrawal R, Zhang L, et al.: Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 2002, 105:602-607.
13. Bers DM, Cardiac excitation-contraction coupling. Nature 2002, 415:198-205.
14. Tappia PS, Hata Horaima L, et al.: Role of oxidative stress in catecholamine-induced changes in cardiac sarcolemmal Ca2+ transport. Arch Biochem Biophys 2001, 387:85-92.
15. Netticadan T, Temsah R, Osada M, Dhalla NS: Status of Ca2+/ calmodulin protein kinase phosphorylation of cardiac SR proteins ischemia-reperfusion. Am J Physiol 1999, 277:C384-C391.
16. Temsah RM, Netticadan T, Chapman D, et al.: Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart. Am J Physiol 1999, 277:H584-H594.
17. Itoh S, Yanagishita T, Aoki S, et al.: Generation of free radicals and the damage done to the sarcoplasmic reticulum during reperfusion injury following brief ischemia in the canine heart. Jpn Circ J 1999, 63:373-378.
18. Sharma R, Davidoff MN: Oxidative stress and endothelial dysfuncion in heart failure. Congest Heart Fail 2002, 8:165-172.
19. Duffy SJ, Gokce N, Holbrook M, et al.: Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension. Am J Physiol Heart Circ Physiol 2001, 280:H528-H534.
20. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of Antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomized placebo-controlled trial. Lancet 2002, 360:23-33.
21. Yusuf S, Dagenais G, Pogue J, et al.: Vitamin E Supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000, 342:154-160.
22. Meagher EA, Barry OP, Lawson JA, et al.: Effects of vitamin E on lipid peroxidation in healthy persons. JAMA 2001, 285:1178-1182.
23. Huang H-Y, Appel LJ, Croft KD, et al.: Effects of vitamin C and vitamins E on in vivo lipid peroxidation: results of a randomized controlled trial. Am J Clin Nutr 2002, 76:549-555.
24. Salonen JT, Nyyssönen K, Salonen R, et al.: Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 2000, 248:377-386.
25. Iannuzzi A, Celentano E, Salvatore P, et al.: Dietary and circulating antioxidant vitamins in relation to carotid plaques in middle-aged women. Am J Clin Nutr 2002, 76:582-587.
26. Sethi R, Takeda N, Nagano M, Dhalla NS: Beneficial effects of vitamin E treatment in acute myocardial infarction. J Cardiovasc Pharmacol Ther 2000, 5:51-58.
27. Venditti P, Masullo P, Di Meo S, Agnisola C: Protection against ischemia-reperfusion induced oxidative stress by vitamin E treatment. Arch Physiol Biochem 1999, 107:27-34.
28. Coombes JS, Powers SK, Demirel HA, et al.: Effects of combined supplementation with vitamin E and alpha-lipoic acid on myocardial performance during in vivo ischaemia-reperfusion. Acta Physiol Scand 2000, 169:261-269.
29. Coombes JS, Powers SK, Hamilton KL, et al.: Improved cardiac performance after ischemia in aged rats supplemented with vitamin E and alpha-lipoic acid. Am J Physiol Regul Integr Comp Physiol 2000, 279:R2149-R2155.
30. Bernátová I, Pechánová O, Babál P, et al.: Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension. Am J Physiol Heart Circ Physiol 2002, 282:H942-H948.
31. Jamroz A, Beltowski J: Antioxidant capacity of selected wines. Med Sci Monit 2001, 7:1198-1202.
32. Saton M, Maulik G, Ray PS, et al. Cardioprotective Effects of grape seed proanthocyanidin against ischemia reperfusion injury. J Mol Cell Cardiol 1999, 31:1289-1297.
33. Pataki T, Bak I, Kovacs P, et al.: Grape seed proanthocyanidins improved cardiac recovery during reperfusion after ischemia in isolated rat hearts. Am J Clin Nutr 2002, 75:894-899.
34. Rays PS, Maulik G, Cordis GA, et al.: The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic Biol Med 1999, 27:160-169.
35. Sato M, Ray PS, Maulik G, et al.: Myocardial protection with red wine extract. J Cardiovasc Pharmacol 2000, 35:263-268.
36. Hale SL, Kloner RA: Effects of resveratrol, a flavinoid found in red wine, on infarct size in an experimental model of ischemia/reperfusion. J Stud Alcohol 2001, 62:730-735.
37. Hung LM, Chen JK, Huang SS, et al.: Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc Res 2000, 47:549-555.
38. Bertelli AA, Migliori M, Panichi V, et al.: Oxidative stress and inflammatory reaction modulation by white wine. Ann N Y Acid Sci 2002, 95:595-301.
39. Cui J, Cordis GA, Tosaki A, et al.: Reduction of Myocardial Ischemia Referfusion Injury with Regular consumption of grapes. Ann N Y Acad Sci 2002, 957:302-307.
40. Woo YJ, Zhang JC, Vijayasarathy C, et al.: Recombinant aden-ovirus-mediated cardiac gene transfer of superoxide dismutase and catalase attenuates postischemic contractile dysfunction. Circulation 1998, 98(19 Suppl):II255-261.
41. Li Q, Bolli R, Qiu Y, et al.: Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits. Circulation 1998, 98:1438-1448.
42. Li Q, Bolli R, Qiu Y, et al.: Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation 2001; 103:1893-1898.
43. Abunasra HJ, Smolenski RT, Morrison K, et al.: Efficacy of adenoviral gene transfer with manganese superoxide dismutase and endothelial nitric oxide synthase in reducing ischemia and reperfusion injury. Eur J Cardiothorac Surg 2001, 20:153-158.
44. Yoshida T, Maulik N, Engelman RM, et al.: Targeted disruption of the mouse Sod I gene makes the hearts vulnerable to ischemic reperfusion injury. Circ Res 2000, 86:264-269.
45. Wang P, Chen H, Qin H, et al.: Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postis-chemic injury. Proc Natl Acad Sci U S A 1998, 95:4556-4560.
46. Zhu HL, Stewart AS, Taylor MD, et al.: Blocking free radical production via adenoviral gene transfer decreases cardiac ischemia-reperfusion injury. Mol Ther 2000, 2:470-475.
47. Svensson EC, Marshall DJ, Woodard K, et al.: Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors. Circulation 1999, 99:201-205.
48. Sakoda T, Kasahara N, Hamamori Y, Kedes L: A high-titer len-tiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes. J Mol Cell Cardiol 1999, 31:2037-2047.